Introduction
Drug and alcohol (ethanol) addiction is a pathological form of learning and memory (Hyman et al., 2006; Kalivas and O'Brien, 2008) . Long-term potentiation (LTP) of AMPA receptor (AMPAR)-mediated synaptic response, a cellular substrate of learning and memory (Bliss and Collingridge, 1993; Malenka and Nicoll, 1999) , is modulated or triggered by exposure to drugs of abuse (Kauer and Malenka, 2007; Russo et al., 2010; Luscher and Malenka, 2011; McCool, 2011) . For examples, in vivo cocaine exposure elicits NMDA receptor (NMDAR)-dependent LTP in the ventral tegmental area (VTA) (Ungless et al., 2001) , and aberrant synaptic plasticity has been shown to contribute to the development of compulsive drug-seeking andtaking (Kauer and Malenka, 2007; Russo et al., 2010; Luscher and Malenka, 2011; McCool, 2011) .
The dorsal striatum, a subcortical brain region important for proper motor function (Graybiel et al., 1994) , also plays an important role in behaviors that are associated with drug addiction (Yin and Knowlton, 2006) . The dorsal striatum can be also divided into two subregions: the dorsolateral striatum (DLS, equivalent of the putamen in human) and the dorsomedial striatum (DMS, equivalent of the caudate in human), which differ in connectivity, synaptic plasticity, and behavioral functions (Gerdeman et al., 2003; Voorn inserm-00858289, version 1 -5 Sep 2013 et al., 2004 Yin and Knowlton, 2006; Belin et al., 2009 ). The DMS is strongly implicated in the acquisition and expression of goal-directed behaviors (Yin and Knowlton, 2006; Corbit and Janak, 2010) . We previously found that withdrawal from acute ex vivo ethanol exposure leads to long-term enhancement of NR2B-containing NMDAR (NR2B-NMDAR) activity in the dorsal striatum (Wang et al., 2007) , and more recently we observed that this enhancement occurs preferentially in the DMS but not the DLS (Wang et al., 2010a) . We also showed that repeated systemic administration of ethanol, as well as cycles of voluntary excessive ethanol intake and withdrawal, results in a long-lasting increase in NMDAR activity in the DMS (Wang et al., 2010a) . Activation of NMDARs is required for the induction of LTP in various brain regions such as the hippocampus and cortex (Bliss and Collingridge, 1993; Malenka and Nicoll, 1999) as well as in the dorsal striatum (Calabresi et al., 1992; Partridge et al., 2000; Shen et al., 2008 ).
Therefore, we tested the hypothesis that repeated cycles of ethanol exposure and withdrawal induce long-lasting NMDAR-dependent neuroadaptations in AMPAR activity that may contribute to mechanisms underlying the expression and/or maintenance of excessive ethanol intake.
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Materials and Methods
Reagents
Anti-GluR1 (04-855) and anti-GluR2 (MAB397) antibodies were obtained from Millipore. Antiglyceraldehyde-3-phosphate dehydrogenase (GAPDH) (sc25778) antibody and all of the horseradish peroxidase (HRP)-conjugated secondary antibodies were purchased from Santa Cruz Biotechnology. Enhanced chemiluminescence (ECL) reagents were from GE Healthcare. Electrophysiology Slice preparation has been described previously (Wang et al., 2010a) . Briefly, coronal sections of the striatum (300 µm) were cut in an ice-cold solution containing the following (in mM): 40 NaCl, 143.5 sucrose, 4 KCl, 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 0.5 CaCl 2 , 7 MgCl 2 , 10 glucose, 1 sodium ascorbate, and 3 sodium pyruvate, saturated with 95% O 2 and 5% CO 2 . Slices were then incubated in the same solution at 32°C for 45 min before being transferred to a chamber that contained an external solution composed of (in mM): 125 NaCl, 2.5 KCl, 2.5 CaCl 2 , 1.3 MgCl 2 , 1.25 NaH 2 PO 4 , 25 NaHCO 3 , and 10 glucose, saturated with 95% O 2 and 5% CO 2 . Slices were stored in the external solution at room temperature until use.
Whole-cell recording. NMDA-induced currents and AMPAR-mediated miniature excitatory postsynaptic currents (mEPSCs) (Wang et al., 2010a) were measured as described previously (Wang et al., 2010b) . AMPA-induced currents were measured as described in (Borgland et al., 2006) . Specifically, AMPA (0.2 µM) was bath applied for 30 sec in the presence of the AMPAR desensitization blocker, cyclothiazide (100 µM). NMDA/AMPA ratios were measured as described in (Ungless et al., 2001 
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Field potential recording. Extracellular field recordings were conducted as described in (Yin et al., 2007; Schotanus and Chergui, 2008) . Field excitatory postsynaptic potential/population spikes (fEPSP/PS) were measured in the presence of 100 µM picrotoxin to block GABA A receptors and a dopamine D2 receptor inhibitor, sulpiride (20 µM) that suppresses the induction of long-term depression (LTD) (Shen et al., 2008) . fEPSP/PS were blocked by the AMPAR antagonist NBQX (data not shown). LTP was induced by 2 trains of high frequency stimulation (HFS) at an interval of 10 sec. Each train contains 100 pulses at 100 Hz.
DMS tissue collection and processing, synaptosomal membrane preparation, and western blot
analysis. The methods used herein have been described previously (Wang et al., 2010a) .
DMS tissue collection and processing. DMS were dissected and homogenized in ice-cold radio immunoprecipitation assay (RIPA) buffer (in mM: 50 Tris-Cl, 5 EDTA, 120 NaCl, and 1% NP-40, 0.1% deoxycholate, 0.5% SDS, protease and phosphatase inhibitor cocktail inhibitors).
Synaptosomal membrane preparation. DMS tissue was homogenized in a glass homogenizer containing 500 µl of ice-cold Krebs-sucrose buffer (in mM: 125 NaCl, 1.2 KCl, 1.2 MgSO 4 , 1.2 CaCl 2 , 22 Na 2 CO 3 , 1.2 NaH 2 PO 4 , 10 glucose, and 320 sucrose, pH 7.4) in the presence of protease and phosphatase inhibitors. The homogenate was centrifuged at 1,000 g for 10 min at 4°C to pellet heavy membranes and debris (P1). The supernatant (S1) was collected and centrifuged at 16,000 g at 4°C for 20 min to pellet the synaptosomal membrane fraction (P2). P2 was re-suspended in 100 µl RIPA buffer. Protein concentration was determined using the BCA TM protein assay kit.
Western blot analysis. Samples were separated on NuPAGE 4-12% Bis-Tris gradient gels. After an overnight transfer at 4 o C onto nitrocellulose membranes, blots were blocked in 5% milk/TBST inserm-00858289, version 1 -5 Sep 2013
for 1 hr before probing with anti-GluR1 (1:1000) or anti-GluR2 (1:1000) antibodies followed by HRP-conjugated secondary antibodies. GAPDH was used as a loading control. Immunoreactivity was detected using ECL plus. The optical density of the relevant immunoreactive band was quantified using the NIH Image 1.63 program.
In vivo systemic administration of ethanol
The procedure is similar to the one described previously (Wang et al., 2010a) . Briefly, Sprague
Dawley rats were administered intraperitoneally (i.p.) with ethanol (20%, 2 g/kg) or saline once a day for 7 consecutive days. Sixteen hrs after the 7 th treatment, striatal slices containing the DMS were prepared for electrophysiological recordings or DMS tissues were dissected out for biochemical measurements.
Behavioral procedures
Intermittent access two-bottle choice procedure
The procedure is similar to the one described previously (Wang et al., 2010a) . Briefly, LongEvans rats were given 24-hr concurrent access to 1 bottle of 20% ethanol (v/v) in water and 1 bottle of water starting at 11:00 a.m. on Monday, Wednesday, and Friday, with 24-or 48-hr ethanol-deprivation periods between the ethanol-drinking sessions. The water and ethanol bottles were weighed after 24 hrs of access. Experiments started after a stable baseline of consumption was achieved (average of 6 g/kg/24 hrs). The control groups had access to 2 bottles of water throughout the duration of the experiment.
Operant ethanol self-administration
Long-Evans rats were first trained to consume high levels of ethanol using the intermittent-access inserm-00858289, version 1 -5 Sep 2013
20% ethanol 2-bottle choice drinking procedure as described previously (Wang et al., 2010a) .
After achieving a stable baseline of intake, rats were trained to self-administer a 20% ethanol solution in an operant self-administration chamber. After 2-3 nights in the chamber to allow acquisition of lever-press response for ethanol under a Fixed Ratio 1 (FR1), operant sessions were conducted 5 days per week, with the schedule requirement increasing to Fixed Ratio 3 (FR3), and the length of session was shortened from 60 to 30 min over the first 2 weeks. Animals had ad libitum access to food and water in their home cages but not during the 30-min session of operant self-administration. After 1 month of training, surgery was conducted to implant cannulae.
Operant sucrose self-administration. Long-Evans rats were initially trained under FR1 using 8% sucrose (w/v) during 2 overnight sessions. The FR schedule was then progressively increased to FR3, and the sucrose concentration was progressively decreased to 1.5%, while the length of the session was shortened to 30 min. These procedures were chosen to obtain lever-press activity similar to that observed in operant ethanol self-administration. After 1 month of training, surgery was conducted to implant cannulae.
Cannulae implantation and treatment. Bilateral guide cannulae (26 ga) were implanted in the DMS (1.2 mm anterior to bregma, 1.5 mm mediolateral, 4.2 mm ventral to bregma, according to (Paxinos and Watson, 2007) . After 4 days of recovery, rats were returned to the self- Histology. Rats implanted with cannulae were anesthetized by i.p. injection of pentobarbital and transcardially perfused with 4% paraformaldehyde. Locations of cannulae were verified in 50-µm coronal sections stained with thionin to allow visualization of probe tracks in the DMS. Only subjects with cannulae located within the DMS were included for statistical analysis.
Statistical analysis
All data are expressed as mean ± SEM. The electrophysiological data were analyzed by normalizing the peak amplitudes of fEPSP/PS to those during baseline (0-10 min prior to HFS).
Data were analyzed using two-way ANOVA with repeated measures (RM-ANOVA), followed by the Student-Newman-Keuls (SNK) post hoc test as previously described (Wang et al., 2010a) .
The biochemical data were analyzed by calculating the ratio of the intensity of the immunoreactive band of interest to GAPDH, and the resultant data were analyzed using an unpaired, two-tailed t test. Behavioral data were analyzed using one-way RM-ANOVA, followed by the SNK test. 
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Ex vivo ethanol-mediated facilitation of LTP induction in the DMS requires activation of
NR2B-NMDARs
We previously found that the ethanol withdrawal-induced increase in NMDAR activity is mediated by the NR2B-NMDARs (Wang et al., 2007; Wang et al., 2010a; Wang et al., 2011) .
Thus, we examined whether NR2B is required for the ethanol-mediated facilitation of LTP induction. Striatal slices from Sprague Dawley rats were acutely exposed to, and withdrawn from, ethanol and HFS was delivered in the presence of the NR2B-NMDAR antagonist, Ro 25-6981.
As shown in Fig. 2 
Repeated in vivo administration of ethanol induces an NR2B-NMDAR-dependent facilitation of LTP in the DMS
Previously, we showed that repeated daily systemic administration of ethanol (2 g/kg, i.p.) produces a long-lasting upregulation of NMDAR function in the DMS, which is observed even 16 hrs after the last ethanol exposure (Wang et al., 2010a) . We used the same procedure to determine whether in vivo ethanol exposure and withdrawal facilitates LTP induction in this brain inserm-00858289, version 1 -5 Sep 2013 region. Sprague Dawley rats were systemically treated with ethanol (2 g/kg, i.p.) or saline for 7 successive days and LTP was measured in DMS slices prepared 16 hrs after the last ethanol administration. As shown in Fig. 3 , HFS induced a significant increase in LTP of fEPSP/PS in slices from ethanol-treated rats (SNK test, q = 6.64, p < 0.001 vs. baseline), but not in slices from saline-treated animals (SNK test, q = 2.04, p = 0.17 vs. baseline). Post hoc SNK tests show that the amplitude of fEPSP/PS during the LTP phase is significantly higher in the ethanol group than in the control (q = 5.28, p < 0.001, Fig. 3B ). These results indicate that repeated cycles of in vivo ethanol exposure and withdrawal facilitate the induction of LTP in the DMS.
In order to confirm that the NR2B-NMDAR is also required for the in vivo ethanolmediated facilitation of LTP, rats received systemic administrations of ethanol or saline once a day for 7 consecutive days and striatal slices were prepared 16 hrs after the last treatment. HFS was then delivered in the presence of Ro 25-6981. As shown in Repeated systemic administration of ethanol and excessive ethanol intake produce a longlasting increase in the protein levels of synaptic AMPAR subunits in the DMS Next, we set out to determine the molecular mechanism that may underlie the ethanolmediated facilitation of LTP. Activation of NMDARs during LTP induction causes the insertion of new AMPARs from intracellular compartments into the synaptic membranes, leading to synaptic strengthening, e.g., expression of LTP (Malinow and Malenka, 2002; Kerchner and inserm-00858289, version 1 -5 Sep 2013 Nicoll, 2008; Ho et al., 2011) . We hypothesized that one of the consequences of in vivo ethanolmediated increases in NMDAR activity is the increase of membranal insertion of AMPARs in the DMS. To test this possibility, we first examined whether repeated systemic administration of ethanol leads to increased synaptic localization of AMPARs in the DMS. We used the same procedure of repeated daily systemic administration of Sprague Dawley rats with ethanol (2 g/kg, i.p.) or vehicle as described above. The levels of two major striatal AMPAR subunits, GluR1 and GluR2, were measured in total homogenates and in synaptosomal membranes 16 hrs after the last ethanol or vehicle treatment. We found that the immunoreactivities of GluR1 and GluR2 subunits were significantly higher in the synaptosomal fractions, but not in the total homogenates, of the DMS from ethanol-treated rats than those from saline-treated animals [t (4) = -2.92, p < 0.05 for synaptosomal GluR1; t (4) = -3.07, p < 0.05 for synaptosomal GluR2; t (4) = 0.70, p > 0.05 for total GluR1; t (4) = 0.55, p > 0.05 for total GluR2; Fig. 4A ]. These results suggest that repeated systemic administration of ethanol leads to a long-lasting increase in the synaptic localization of the GluR1 and GluR2 subunit-containing AMPARs in the DMS.
Next, we examined whether a similar increase in the synaptic levels of GluR1 and/or GluR2 AMPAR subunits can also be the consequence of cycles of excessive ethanol intake and withdrawal. Using the intermittent access 2-bottle choice drinking procedure, Long-Evans rats underwent repeated cycles of excessive consumption of 20% ethanol resulting in an average consumption of 6 g/kg/24 hrs (Wang et al., 2010a) , the DMS tissues were dissected out 1 day after the completion of the last ethanol-drinking session, and the protein levels of GluR1 and We further measured lever-press responding for a non-drug reinforcing substance, sucrose, after an intra-DMS infusion of NBQX. This experiment was conducted to verify that the inhibitory effect of NBQX on ethanol self-administration is not due to locomotor inserm-00858289, version 1 -5 Sep 2013 deficits, and to determine whether the action of the inhibitor in the DMS is specific for ethanol or due a reduction of general instrumental learning and motivational processes. To do so, rats were trained to self-administer a 1.5% sucrose solution (Wang et al., 2010a) , and 15 min before the testing session, NBQX or vehicle was infused into the DMS. As shown in Fig. 5B , intra-DMS infusion of NBQX did not significantly alter lever presses for sucrose: one-way RM-ANOVA analysis showed no main effect of NBQX on operant responding for sucrose [F (2,15) = 0.11, p = 0.9]. This result suggests that NBQX does not alter locomotor activity or general reward-motivated behaviors. Together, these results indicate that the ethanol-mediated increase in the activity of AMPARs in the DMS is required for self-administration of ethanol.
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Discussion
In the present study we demonstrate that both ex vivo and repeated cycles of in vivo ethanol exposure and withdrawal facilitate the induction of LTP in the DMS in an NR2B-NMDAR-dependent manner. Consistent with the concept that LTP is mediated by the insertion of AMPARs into the synaptic membranes, we found that both repeated systemic administration of ethanol and excessive ethanol intake cause a long-lasting increase in synaptic AMPAR levels.
Importantly, we show that inhibition of AMPARs in the DMS significantly attenuates operant self-administration of ethanol, but not of sucrose. Together, these results indicate that the ethanolmediated increase in NMDAR activity in the DMS leads to the insertion of AMPARs into the synaptic sites and thus expression of LTP, which in turn contributes to the expression and/or the maintenance of excessive ethanol-drinking behaviors. In the present study, we found that ethanol exposure and withdrawal induces facilitation of LTP, which is abolished by the NR2B-NMDAR antagonist, Ro 25-6981. These results suggest that ethanol treatments facilitate LTP induction via the upregulation of NR2B-NMDAR activity.
This finding is in line with the notion that the NR2B/NR2A ratio controls the threshold for inducing LTP (Yashiro and Philpot, 2008) . Compared to NR2A-containing NMDARs (NR2A-
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NMDARs), NR2B-NMDARs mediate longer currents (Monyer et al., 1994) , carry more Ca 2+ per unit of current (Sobczyk et al., 2005) , and bind preferentially with CaMKII (Strack and Colbran, 1998; Leonard et al., 1999) , which allows CaMKII to remain active even after dissociation from Ca 2+ /calmodulin (Bayer et al., 2001; Lisman et al., 2012) and is required for LTP induction (Barria and Malinow, 2005; Zhou et al., 2007; Foster et al., 2010) . Previously, we found that the activity of NR2B-, but not NR2A-NMDARs increases following ethanol exposure and withdrawal (Wang et al., 2007; Wang et al., 2010a; Wang et al., 2011) , which indicates an elevated NR2B/NR2A ratio in response to this ethanol treatment that is likely to underlie the facilitation of LTP. The NR2B-NMDAR-dependent facilitation of LTP in response to ethanol exposure and withdrawal was observed recently in the bed nucleus of the stria teminalis (BNST) (Wills et al., 2012) . Interestingly, the LTP facilitation in the BNST was thought to be mediated by the increased lateral movement of NR2B-NMDARs from the synaptic to extrasynaptic sites (Wills et al., 2012) , whereas we show that LTP facilitation in the DMS is likely to be mediated by the increased forward trafficking of NR2B-NMDAR from the cytoplasmic into the synaptic membrane. This conclusion stems from the observation that the 7-daily systemic administration of ethanol increases the synaptic, but not total protein levels of NR2B-NMDARs in the DMS (Wang et al., 2010a; Wang et al., 2011) . The difference in the mechanisms underlying ethanolinduced LTP may result from the diverse responses of NMDARs to ethanol exposure in these two brain regions. For example, acute ethanol exposure fails to inhibit NMDAR activity in the presence of Ro 25-6981 in the BNST (Wills et al., 2012), whereas we found that such inhibition is preserved in the DMS (Wang et al., 2007) . Importantly, in the present study we provide evidence to suggest that the mechanism underlying the LTP facilitation in the DMS is associated with enhancement of GluR1 and GluR2 subunits of AMPARs into the synaptic membrane (see below).
Repeated systemic administration of ethanol and excessive ethanol consumption upregulate
synaptic AMPAR levels
We found that repeated systemic ethanol administration, as well as ethanol withdrawal in rats with a history of excessive ethanol intake, leads to an increased trafficking of AMPARs from the cytoplasmic into synaptic sites. Insertion of new AMPARs is thought to underlie LTP (Malinow and Malenka, 2002; Kerchner and Nicoll, 2008) . Thus, the increased insertion of AMPARs in the DMS synapses following in vivo ethanol exposure and withdrawal is likely a consequence of the facilitation of LTP. Importantly, the ethanol-mediated synaptic AMPAR change is also long-lasting: it is observed 24 hrs after withdrawal from excessive ethanol intake.
Surprisingly, we did not observe occlusion of LTP induction in response to ethanol exposure and withdrawal. However, LTP occlusion normally requires prolonged stimulation of a synapse to induce the saturation of LTP, which prevents further LTP induction by a second stimulation of the same synapse (Lledo et al., 1995) . Thus, it is likely that ethanol exposure procedure employed in the present study does not induce a maximal NMDAR-dependent LTP.
We observed that although the synaptic levels of AMPAR GluR1 and GluR2 tissue was dissected out 16 hrs after the 7 th administration, and GluR1 and GluR2 levels in total homogenates (Total) and at synaptosomal membranes (Synaptic) were measured by western blot.
Left, Sample images of total and synaptosomal protein levels of GluR1 and GluR2. Right, Bar graph summarizing mean protein levels of GluR1 and GluR2 in saline-and ethanol-treated animals. *p < 0.05. n = 3 for each group. B, Excessive ethanol intake upregulates synaptic GluR1
and GluR2 subunits of AMPARs. Long-Evans rats underwent an intermittent-access to 20% ethanol in a 2-bottle choice drinking procedure for 7-8 weeks, DMS tissues were dissected 1 day after the last ethanol drinking session (ethanol withdrawal, EW), and protein levels of GluR1 and GluR2 in total homogenates and synaptosomal membranes were measured. Left, Sample images of total and synaptosomal protein levels of GluR1 and GluR2. Right, Average of protein levels of GluR1 and GluR2 subunits in water controls (Water) and ethanol (EW)-treated animals. *p < 0.05. n = 7 (Water) and 6 (EW) for total GluR1; 7 (Water) and 8 (EW) for total GluR2; 5 (Water) and 5 (EW) for synaptic GluR1, and 7 (Water) and 7 (EW) for synaptic GluR2. 
